4
Changes in Ownership
Cartesian Therapeutics, Inc. Filed Acc 0001453687-25-000040
Chief Technology Officer sold 4,875 shares at an average $16.78 ($81,790)
From the SEC's structured data for this filing
Trades in this filing
Kurtoglu Metin · Chief Technology Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-01-03 | Sale : show line 1 in the form | −2,417 | $16.72 | $40,417 | 64,716 | D |
| 2025-01-06 | Sale : show line 2 in the form | −2,458 | $16.83 | $41,374 | 62,258 | D |
| Open-market sales · 4,875 sh · avg $16.78 · $81,790 | ||||||
Loading xslF345X05/wk-form4_1736298335.xml…